本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Oric Pharmaceuticals Inc.

9.24
-0.3900-4.05%
盤後9.06-0.1800-1.95%19:46 EDT
成交量:105.01萬
成交額:970.88萬
市值:7.87億
市盈率:-4.91
高:9.66
開:9.64
低:9.03
收:9.63
52周最高:14.67
52周最低:3.90
股本:8,521.84萬
流通股本:5,545.50萬
量比:1.37
換手率:1.89%
股息:- -
股息率:- -
每股收益(TTM):-1.8805
每股收益(LYR):-1.8335
淨資產收益率:-48.45%
總資產收益率:-30.87%
市淨率:3.58
市盈率(LYR):-5.04

資料載入中...

2024/11/13

重要事件披露

Form 8-K - Current report
2024/08/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/12

重要事件披露

Form 8-K - Current report
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/06

重要事件披露

Form 8-K - Current report
2024/03/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/29

重要事件披露

Form 8-K - Current report
2024/03/11

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/11

重要事件披露

Form 8-K - Current report
2024/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/01

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/01

SEC問詢函

Form CORRESP - Correspondence
2024/01/30

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/26

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals